Skip to main content
Showing 35,658 results
Harm reduction
Liz Evans And InSite’s Insightful Story
Editor's pick
Medium
1 March 2016
PrEP
What People are Saying About Approval Of PrEP in Canada
Editor's pick
Positive Lite
1 March 2016
Finance & funding
Investing in prevention: is it cost-effective?
Editor's pick
Public Health England
1 March 2016
Conference announcements & declarations
Really Rapid Review — CROI 2016, Boston
Editor's pick
NEJM Journal Watch
1 March 2016
PrEP
Canada Approves Drug That Stops HIV Transmission, but It’s Still Really Expensive
Editor's pick
Vice
29 February 2016
The search for a cure
Experimental TLR7 agonist suppresses HIV-like virus in monkeys after ART interruption
News
29 February 2016
Epidemiology
Your lifetime risk of HIV by race, state and sexual preference — in four simple charts
Editor's pick
Washington Post
29 February 2016
Access to healthcare
His Job Is to Sell a $1,000 Pill for $10 Without Losing Money
Editor's pick
Bloomberg
29 February 2016
Cancer
Study does not support routine HPV quadrivalent vaccination to protect against anal cancer in older people living with HIV
News
29 February 2016
PrEP science
‘On-demand’ rectal microbicide gel has reasonable tolerability and acceptability – daily less so
News
28 February 2016
Treatment outcomes & life expectancy
Life expectancy in HIV-positive people in the US still lags 13 years behind HIV-negative people
News
28 February 2016
Global health targets
Option B+ has enabled Malawi to make significant progress towards 90-90-90
News
27 February 2016
PrEP
Condom use in French PrEP trial: half only used PrEP, a quarter used condoms and PrEP, one in six used neither
News
26 February 2016
New & experimental HIV treatments
European CHMP Adopts Positive Opinion for Gilead’s Fixed-Dose Combination Descovy® (Emtricitabine/Tenofovir Alafenamide) for the Treatment of HIV
Editor's pick
Gilead press release
26 February 2016
Finance & funding
Uganda risks losing Global Fund grants
Editor's pick
Key Correspondents
26 February 2016
People & personal stories
John Gagnon, Sociologist Who Explored Human Sexuality, Dies at 84
Editor's pick
New York Times
26 February 2016
Pharmaceutical industry
HIV unit emerges as 'critical' driver of GSK growth
Editor's pick
Financial Times
26 February 2016
TB treatment
Empirical TB treatment comes up short again
News
26 February 2016
Transmission & prevention
Modern HIV Prevention: What’s Next For Women?
Editor's pick
International AIDS Society
26 February 2016
Hepatitis C treatment
Sofosbuvir/ledipasvir for 6 weeks cures HCV in HIV-positive people with acute HCV if viral load is low
News
26 February 2016
People & personal stories
Interview with PrEP Warrior Damon L. Jacobs
Editor's pick
HIV Smart
26 February 2016
Cardiovascular disease
Cardiovascular Risk Tools for HIV Go Head-to-Head in Large U.S. Study
Editor's pick
The Body Pro
26 February 2016
Neurological & cognitive problems
Antidepressant May Improve Cognitive Symptoms in People with HIV
Editor's pick
Hopkins Medicine
26 February 2016
The search for a cure
Immunotherapy agent can disrupt viral reservoir in SIV-infected monkeys
Editor's pick
Emory Health Sciences
26 February 2016
Pagination
First page
« First
Previous page
‹ Previous
…
Page
594
Page
595
Page
596
Page
597
Current page
598
Page
599
Page
600
Page
601
Page
602
…
Next page
Next ›
Last page
Last »